- Report
- October 2024
- 193 Pages
From €3161EUR$3,545USD£2,743GBP
€3512EUR$3,939USD£3,048GBP
- Report
- October 2025
- 189 Pages
Global
From €3161EUR$3,545USD£2,743GBP
€3512EUR$3,939USD£3,048GBP
- Report
- October 2025
- 185 Pages
Global
From €3161EUR$3,545USD£2,743GBP
€3512EUR$3,939USD£3,048GBP
- Report
- October 2025
- 183 Pages
Global
From €3161EUR$3,545USD£2,743GBP
€3512EUR$3,939USD£3,048GBP
- Report
- October 2025
- 188 Pages
Global
From €3161EUR$3,545USD£2,743GBP
€3512EUR$3,939USD£3,048GBP
- Report
- October 2025
- 190 Pages
Global
From €3161EUR$3,545USD£2,743GBP
€3512EUR$3,939USD£3,048GBP
- Report
- February 2025
- 240 Pages
Global
From €2398EUR$2,690USD£2,081GBP
- Report
- October 2025
- 483 Pages
Global
From €5216EUR$5,850USD£4,527GBP
- Report
- October 2025
- 485 Pages
Global
From €5216EUR$5,850USD£4,527GBP
- Report
- October 2025
- 184 Pages
Global
From €5216EUR$5,850USD£4,527GBP
- Report
- October 2025
- 380 Pages
Global
From €5216EUR$5,850USD£4,527GBP
- Report
- October 2025
- 250 Pages
Global
From €4003EUR$4,490USD£3,474GBP
- Report
- September 2025
- 250 Pages
Global
From €4003EUR$4,490USD£3,474GBP
- Report
- September 2025
- 250 Pages
Global
From €4003EUR$4,490USD£3,474GBP
- Report
- September 2025
- 250 Pages
Global
From €4003EUR$4,490USD£3,474GBP
- Report
- September 2025
- 250 Pages
Global
From €4003EUR$4,490USD£3,474GBP
- Report
- July 2025
- 175 Pages
Global
From €4003EUR$4,490USD£3,474GBP
- Report
- January 2025
- 175 Pages
Global
From €4003EUR$4,490USD£3,474GBP
- Report
- January 2025
- 175 Pages
Global
From €4003EUR$4,490USD£3,474GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1070EUR$1,200USD£929GBP
€1337EUR$1,500USD£1,161GBP

Valproate is a drug used to treat a variety of neurological disorders, including epilepsy, bipolar disorder, and migraine headaches. It is a type of anticonvulsant, meaning it works to reduce the frequency and severity of seizures. Valproate is also used to treat mania and depression, as well as to prevent migraine headaches. Valproate is available in both oral and intravenous forms, and is often prescribed in combination with other medications.
Valproate is a widely used drug in the Central Nervous System (CNS) drug market. It is used to treat a variety of neurological disorders, including epilepsy, bipolar disorder, and migraine headaches. Valproate is also used to treat mania and depression, as well as to prevent migraine headaches. Valproate is available in both oral and intravenous forms, and is often prescribed in combination with other medications.
Some companies in the Valproate market include AbbVie, GlaxoSmithKline, Johnson & Johnson, Pfizer, and Sanofi. Show Less Read more